Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model
Authors
Keywords
-
Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume 54, Issue 3, Pages 903-912
Publisher
IOS Press
Online
2016-08-17
DOI
10.3233/jad-160533
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting the Endocannabinoid System in Alzheimer's Disease
- (2017) Jeremy Koppel et al. JOURNAL OF ALZHEIMERS DISEASE
- An Introduction to the Endogenous Cannabinoid System
- (2016) Hui-Chen Lu et al. BIOLOGICAL PSYCHIATRY
- Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence
- (2016) Marco Colizzi et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Amyloid-β alters ongoing neuronal activity and excitability in the frontal cortex
- (2014) Vered Kellner et al. NEUROBIOLOGY OF AGING
- β-Amyloid Inhibits E-S Potentiation through Suppression of Cannabinoid Receptor 1-Dependent Synaptic Disinhibition
- (2014) Adrienne L. Orr et al. NEURON
- Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice
- (2014) David Cheng et al. PSYCHOPHARMACOLOGY
- Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic
- (2014) Ester Aso et al. Frontiers in Pharmacology
- Δ9-THC-Caused Synaptic and Memory Impairments Are Mediated through COX-2 Signaling
- (2013) Rongqing Chen et al. CELL
- Synaptic Targets of 9-Tetrahydrocannabinol in the Central Nervous System
- (2013) A. F. Hoffman et al. Cold Spring Harbor Perspectives in Medicine
- Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice
- (2012) Ana María Martín-Moreno et al. Journal of Neuroinflammation
- Activation of the CB2 receptor system reverses amyloid-induced memory deficiency
- (2012) Jiang Wu et al. NEUROBIOLOGY OF AGING
- Endocannabinoid Signaling and Synaptic Function
- (2012) Pablo E. Castillo et al. NEURON
- Brain excitability and connectivity of neuronal assemblies in Alzheimer's disease: From animal models to human findings
- (2012) Marcello D’Amelio et al. PROGRESS IN NEUROBIOLOGY
- Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia
- (2012) Isidro Ferrer PROGRESS IN NEUROBIOLOGY
- Preventing Alzheimer's Disease
- (2012) D. J. Selkoe SCIENCE
- Molecular reorganization of endocannabinoid signalling in Alzheimer’s disease
- (2011) Jan Mulder et al. BRAIN
- Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging
- (2011) O. Albayram et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis
- (2010) Derick T Wade et al. Multiple Sclerosis Journal
- Alzheimer's disease; taking the edge off with cannabinoids?
- (2007) V A Campbell et al. BRITISH JOURNAL OF PHARMACOLOGY
- Dose translation from animal to human studies revisited
- (2007) Shannon Reagan-Shaw et al. FASEB JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now